2016
DOI: 10.1111/jdv.13529
|View full text |Cite
|
Sign up to set email alerts
|

Effective treatment for sensitive skin: 4‐t‐butylcyclohexanol and licochalcone A

Abstract: In vitro and in vivo data indicate that the combination of the TRPV1 antagonist 4-t-butylcyclohexanol and the potent anti-inflammatory licochalcone A provide an effective active ingredient concept for the treatment of sensitive skin, as the topical application resulted in an immediate relief from symptoms such as erythema and stinging.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
36
0
2

Year Published

2018
2018
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 44 publications
(41 citation statements)
references
References 32 publications
0
36
0
2
Order By: Relevance
“…There is limited published data describing the effect of topical serums on sensitive skin. Clearly sunscreen use will reduce skin erythema but many plant extracts and oils/acids as well as beta glucans, sodium hyaluronate, glycerine, 4‐t‐butylcyclohexanol, tranexamic acid, oxyresveratrol, glutathione disulphide, licochalcone A and niacinamide are also known to reduce skin redness .…”
Section: Discussionmentioning
confidence: 99%
“…There is limited published data describing the effect of topical serums on sensitive skin. Clearly sunscreen use will reduce skin erythema but many plant extracts and oils/acids as well as beta glucans, sodium hyaluronate, glycerine, 4‐t‐butylcyclohexanol, tranexamic acid, oxyresveratrol, glutathione disulphide, licochalcone A and niacinamide are also known to reduce skin redness .…”
Section: Discussionmentioning
confidence: 99%
“…Liberal applications of plain emollients are also sensible therapeutic measures to reduce TEWL and increase epidermal thickness. Other treatments documented in the literatures like TRPV 1 antagonist 4-tbutylcyclohexanol and licochalcone, low level energy device like laser and intense pulse light, cosmetic products and ingestion of probiotics may not be applicable due to the inaccessibility and inapplicability of these therapeutic measures in our specific case [21][22][23][24]. The DLQI on the last clinic visit on 10 April 2019 showed a patient self-reported improvement of health, emotion, anxiety and happiness status.…”
Section: Discussionmentioning
confidence: 99%
“…Through disentangling the relationship between the pathogenesis of sensitive skin and TRP channels and TRPV1 antagonist, it indicates that trans-4-tert-butylcyclohexanol and licochalcone are effective in treating sensitive skin [36]. Pimecrolimus down regulates TRP receptors, decrease TWEL and may increase epidermal thickness [37,38].…”
Section: Managementmentioning
confidence: 99%